2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Progressive Supranuclear Palsy (PSP): new trials by email Literature Review of Progressive Supranuclear Palsy (PSP) trials Research Report on Progressive Supranuclear Palsy (PSP)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients DaTSCAN™ Ioflupane (123I) Injection - Parkinsonian Syndrome, Parkinson Disease(PD) | Phase 3 | Completed | GE Healthcare | 172 | 2020-06-28 | 2023-10-16 |
| Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy Rivastigmine, Placebo - Progressive Supranuclear Palsy (PSP) | Phase 3 | Completed | Assistance Publique Hopitaux De Marseille | 106 | 2016-07-26 | 2023-07-20 |
Supranuclear Palsy, Progressive (2) · Essential Tremor (1) · Multiple System Atrophy (1) · Parkinson Disease (1) · Parkinsonian Disorders (1)
Basal Ganglia Diseases (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cranial Nerve Diseases (2) · Eye Diseases (2) · Movement Disorders (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Neurologic Manifestations (2) · Ocular Motility Disorders (2) · Ophthalmoplegia (2) · Paralysis (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Tauopathies (2)
Injections (1) · Iodine-123 (1) · Rivastigmine (1) · ioflupane (1)
Assistance Publique Hopitaux De Marseille (1) · GE Healthcare (1)
China (1) · France (1)
2016 (1)